Cargando…
Health Canada’s use of expedited review pathways and therapeutic innovation, 1995–2016: cross-sectional analysis
OBJECTIVES: This study examines the use of expedited approval pathways by Health Canada over the period 1995 to 2016 inclusive and the relationship between the use of these pathways and the therapeutic gain offered by new products. DESIGN: Cross-sectional study. DATA SOURCES: Therapeutic Products Di...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6119438/ https://www.ncbi.nlm.nih.gov/pubmed/30166310 http://dx.doi.org/10.1136/bmjopen-2018-023605 |